Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 04 Mar 2023
United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...
Read Full NewsNovartis plans to submit regulatory applications for ianalumab in early 2026.
Pulmonary arterial hypertension treatment continues to evolve with new therapies and strategies.
If approved, lecanemab-irmb would provide an at-home subcutaneous injection option for both treatment initiation and maintenance dosing for patients with early-stage Alzheimer disease.
A recent study linked maternal diabetes to a doubled risk of multiple sclerosis in offspring, highlighting prenatal factors in MS susceptibility.
Head-to-head PET imaging data indicated that valbenazine achieves significantly higher VMAT2 target occupancy than deutetrabenazine XR at therapeutic doses, with both treatments remaining well tolerated.
The FDA raised no objections to Lexicon Pharmaceuticals’ pilavapadin for a phase 3 program, which will include 2-arm registrational studies, in patients with diabetic peripheral neuropathic pain.
McGill emphasizes new exciting data shared at ACR 2025.
1.
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.
2.
Routine breast cancer screening can bring better outcomes for patients
3.
In a recent study, Kencur ginger's anti-cancer properties were discovered.
4.
La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.
5.
In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.
1.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
2.
Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications
3.
Unlocking the Mysteries of ICD 10 Code Normocytic Anemia
4.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
5.
The Danger of Methemoglobinemia and How to Prevent It
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge